Pro-inflammatory Th17 cell populations, which are distinguished by the expression of CCR6 and include Th17, Th1/Th17, and Th17.1 cells, are elevated and more active in various autoimmune diseases including RA, systemic lupus erythematosus, and inflammatory bowel diseases (6–9). Here, CCR6 is linked to autoimmune disease.